

Central line-associated bloodstream rates fell 36% following the intervention as an unexpected secondary gain, resulting in further savings related to treating this nonreimbursable hospital-acquired condition. Other cost savings were reflected in areas of flushing, flushing disposables, and in a decrease in needleless connector consumption.
#SIGMA ASC 434 DRIVER ACTIVATOR#
Over the course of the 26-month study, Hartford Hospital experienced a 69% total reduction in tissue plasminogen activator use representing a total 26-month savings of $107,315. Interventions initiated based on the assessment performed by the team using the define, measure, analyze, improve, and control approach included replacement of negative displacement needleless connectors with antireflux needleless connectors and specialty team assessment before tissue plasminogen activator use. The team utilized a Six Sigma strategy employing the elements define, measure, analyze, improve, and control, which is a disciplined, data-driven methodology that focuses on eliminating defects (waste). Using observation, measurement of performance, and root cause analysis, the hospital's practices, policies, and equipment were evaluated for the process of occlusion management. Central venous access device occlusion and tissue plasminogen activator variability was identified. This occurs by identifying opportunities for improvement that influence efficiency while saving money.Īn investigation of intravenous device-related practices was performed by the nurses of the intravenous access team, pharmacy, and hospital operations at Hartford Hospital using Lean Six Sigma methodology. When we do, we will also revise the last updated date at the top of the Privacy Policy.Continual improvement is a necessary part of hospital culture. However, please be aware that no method of transmission over the internet, or method of electronic storage is 100 secure and we are unable to guarantee the absolute security of the Personal Information we have collected from you. The security of your Personal Information is important to us, and we strive to implement and maintain reasonable, commercially acceptable security procedures and practices appropriate to the nature of the information we store, in order to protect it from unauthorized access, destruction, use, modification, or disclosure. However, if you do not accept cookies, you may not be able to use some portions of our Site.Īffiliates include our parent company and any subsidiaries, joint venture partners or other companies that we control or that are under common control with us. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent.

These third-party service providers have their own privacy policies addressing how they use such information. In addition, we may use third-party services such as Google Analytics that collect, monitor and analyze this type of information in order to increase our Sites functionality. This log data may include information such as your computers Internet Protocol (IP) address, browser type, browser version, the pages of our Site that you visit, the time and date of your visit, the time spent on those pages and other statistics. We use the information that you provide for such purposes as responding to your requests, customizing future shopping for you, improving our service, and communicating with you.
